Valuation: MINDESTA

Market Cap 4.7M 4.13M 3.8M 3.55M 6.67M 443M 6.79M 45.61M 17.67M 218M 17.64M 17.25M 759M P/E 2024
-11.9x
P/E 2025 -22.2x
Enterprise Value 4.7M 4.13M 3.8M 3.56M 6.67M 444M 6.79M 45.64M 17.68M 219M 17.65M 17.26M 760M EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
50.43%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 71 09/09/2014
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%+7.32%-4.97%+2.57% 46.36B
+1.64%+8.82%+381.40%+625.49% 37.88B
+1.31%+11.75%+18.57%-12.30% 31.12B
+2.20%+3.13%+10.15%+55.65% 30.61B
-4.16%-4.44%+8.53%+16.06% 24.69B
+1.12%+16.14% - - 16.25B
+0.25%+13.88%+69.14%+130.52% 14.85B
+0.67%+10.01%+13.01%+22.52% 13.58B
+4.06%+7.91%+105.86%+109.44% 12.95B
Average +0.74%+7.85%+75.21%+118.74% 25.36B
Weighted average by Cap. +0.54%+7.66%+84.37%+137.67%

Financials

2024 2025
Net sales - -
Net income -250K -220K -203K -189K -355K -23.61M -362K -2.43M -941K -11.64M -940K -919K -40.45M -156K -137K -126K -118K -221K -14.71M -225K -1.51M -586K -7.25M -585K -573K -25.2M
Net Debt 16.82K 14.77K 13.61K 12.73K 23.87K 1.59M 24.31K 163K 63.26K 782K 63.16K 61.78K 2.72M 3.46K 3.03K 2.8K 2.61K 4.9K 326K 4.99K 33.55K 12.99K 161K 12.97K 12.69K 558K
Logo MINDESTA
CTT Pharmaceutical Holdings, Inc. specializes in drug delivery systems technology within the pharmaceutical industry. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. It rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. It offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. It is a thin film for treating dogs and cats.
Employees
-